Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

09.09.2021 | case report Open Access

Immune-related hepatitis in a patient with hepatocellular carcinoma treated with nivolumab

memo - Magazine of European Medical Oncology
MD Bernhard Scheiner, MD PhD Matthias Pinter
Wichtige Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


We present a case of a male patient with advanced hepatocellular carcinoma who developed hepatic and dermatological immune-related adverse events during treatment with the immune checkpoint inhibitor nivolumab. We discuss relevant aspects regarding the management of immune-related hepatic adverse events, including the incidence and onset of the event, the requirement for immune-modulating medication, resuming of immunotherapy, and the association between the occurrence of immune-related adverse events and the outcome.

Unsere Produktempfehlungen

Abo für kostenpflichtige Inhalte

Über diesen Artikel